HEADER TRANSFERASE 27-NOV-02 1NA7 TITLE CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II, ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC SUBUNIT; COMPND 5 SYNONYM: CK II; COMPND 6 EC: 2.7.1.37; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS CK2, PROTEIN KINASE, MICROCRYSTALS, THIN-FILM NANOTECHNOLOGY, KEYWDS 2 MICROFOCUS ESRF, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.PECHKOVA,G.ZANOTTI,C.NICOLINI REVDAT 5 16-AUG-23 1NA7 1 REMARK REVDAT 4 27-OCT-21 1NA7 1 SEQADV REVDAT 3 24-FEB-09 1NA7 1 VERSN REVDAT 2 09-DEC-03 1NA7 1 JRNL REVDAT 1 26-AUG-03 1NA7 0 JRNL AUTH E.PECHKOVA,G.ZANOTTI,C.NICOLINI JRNL TITL THREE-DIMENSIONAL ATOMIC STRUCTURE OF A CATALYTIC SUBUNIT JRNL TITL 2 MUTANT OF HUMAN PROTEIN KINASE CK2. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 59 2133 2003 JRNL REFN ISSN 0907-4449 JRNL PMID 14646071 JRNL DOI 10.1107/S0907444903018900 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.NIEFIND,B.GUERRA,L.A.PINNA,O.-G.ISSINGER,D.SCHOMBURG REMARK 1 TITL CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE REMARK 1 TITL 2 CK2 FROM ZEA MAYS AT 2.1 A RESOLUTION REMARK 1 REF EMBO J. V. 17 2451 1998 REMARK 1 REFN ISSN 0261-4189 REMARK 1 DOI 10.1093/EMBOJ/17.9.2451 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.BATTISTUTTA,E.DE MOLINER,S.SARNO,G.ZANOTTI,L.A.PINNA REMARK 1 TITL STRUCTURAL FEATURES UNDERLYING SELECTIVE INHIBITION OF REMARK 1 TITL 2 PROTEIN KINASE CK2 BY ATP SITE-DIRECTED REMARK 1 TITL 3 TETRABROMO-2-BENZOTRIAZOLE REMARK 1 REF PROTEIN SCI. V. 10 2200 2001 REMARK 1 REFN ISSN 0961-8368 REMARK 1 DOI 10.1110/PS.19601 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.PECHKOVA,C.NICOLINI REMARK 1 TITL ACCELERATED PROTEIN CRYSTAL GROWTH BY PROTEIN THIN FILM REMARK 1 TITL 2 TEMPLATE REMARK 1 REF J.CRYST.GROWTH V. 231 599 2001 REMARK 1 REFN ISSN 0022-0248 REMARK 1 DOI 10.1016/S0022-0248(01)01450-6 REMARK 1 REFERENCE 4 REMARK 1 AUTH E.PECHKOVA,C.NICOLINI REMARK 1 TITL PROTEIN NUCLEATION AND CRYSTALLIZATION BY HOMOLOGOUS PROTEIN REMARK 1 TITL 2 THIN FILM TEMPLATE REMARK 1 REF J.CELL.BIOCHEM. V. 85 243 2002 REMARK 1 REFN ISSN 0730-2312 REMARK 1 DOI 10.1002/JCB.10123 REMARK 1 REFERENCE 5 REMARK 1 AUTH E.PECHKOVA,C.NICOLINI REMARK 1 TITL FROM ART TO SCIENCE IN PROTEIN CRYSTALLIZATION BY MEANS OF REMARK 1 TITL 2 THIN-FILM TECHNOLOGY REMARK 1 REF NANOTECHNOLOGY V. 13 460 2002 REMARK 1 REFN ISSN 0957-4484 REMARK 1 DOI 10.1088/0957-4484/13/4/304 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 12448 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1277 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1868 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 216 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2757 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 91 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.36000 REMARK 3 B22 (A**2) : 2.72000 REMARK 3 B33 (A**2) : 1.64000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.25000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 31.82 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NA7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-DEC-02. REMARK 100 THE DEPOSITION ID IS D_1000017711. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9755 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MICROFOCUS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12457 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 29.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1M2R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3500, NAAC, TRIS, PH 8, LB REMARK 280 MODIFIED HANGING DROP METHOD, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.97700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CE2 TYR A 138 O HOH A 354 1.89 REMARK 500 O HOH A 377 O HOH A 378 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 43 -169.38 46.74 REMARK 500 ARG A 47 76.27 -151.62 REMARK 500 TYR A 50 -11.56 -142.91 REMARK 500 ILE A 59 1.66 -63.26 REMARK 500 PRO A 72 51.36 -63.87 REMARK 500 LYS A 74 89.57 77.88 REMARK 500 LYS A 75 -24.37 -37.67 REMARK 500 GLU A 114 -140.20 -67.29 REMARK 500 ASN A 117 66.96 -103.09 REMARK 500 ASP A 120 132.83 -28.07 REMARK 500 TYR A 125 30.79 -82.47 REMARK 500 ASP A 156 42.57 -153.50 REMARK 500 ILE A 174 -169.28 -117.24 REMARK 500 ASP A 175 81.90 47.07 REMARK 500 TRP A 176 34.21 -99.13 REMARK 500 ARG A 191 56.07 -90.03 REMARK 500 ALA A 193 177.18 81.18 REMARK 500 ASP A 205 39.01 70.64 REMARK 500 ASP A 210 -152.48 -146.00 REMARK 500 ASP A 271 22.85 -159.10 REMARK 500 ILE A 272 -20.20 -148.64 REMARK 500 HIS A 286 -153.15 -140.79 REMARK 500 VAL A 328 -163.66 -73.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A6O RELATED DB: PDB REMARK 900 PROTEIN KINASE CK2 (CATALYTIC SUBUNIT) FROM ZEA MAYS REMARK 900 RELATED ID: 1F0Q RELATED DB: PDB REMARK 900 ALPHA SUBUNIT OF PROTEIN KINASE CK2 IN COMPLEX WITH THE NUCLEOTIDE REMARK 900 COMPETITIVE INHIBITOR EMODIN REMARK 900 RELATED ID: 1M2Q RELATED DB: PDB REMARK 900 1,8-DI-HYDROXY-4-NITRO-XANTEN-9-TITONE/CK2 KINASE COMPLEX REMARK 900 RELATED ID: 1M2R RELATED DB: PDB REMARK 900 5,8-DI-AMINO-1,4-DI-HYDROXY- ANTHRAQUINONE/CK2 KINASE COMPLEX DBREF 1NA7 A 1 329 UNP P68400 CSK21_HUMAN 1 329 SEQADV 1NA7 ALA A 27 UNP P68400 GLU 27 ENGINEERED MUTATION SEQADV 1NA7 ASN A 76 UNP P68400 LYS 76 ENGINEERED MUTATION SEQRES 1 A 329 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 A 329 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 A 329 ALA SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 A 329 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 A 329 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 A 329 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS ASN LYS ILE SEQRES 7 A 329 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 A 329 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 A 329 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 A 329 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 A 329 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 A 329 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 A 329 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 A 329 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 A 329 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 A 329 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 A 329 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 A 329 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 A 329 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 A 329 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 A 329 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 A 329 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 A 329 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 A 329 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 A 329 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 A 329 THR VAL VAL LYS FORMUL 2 HOH *91(H2 O) HELIX 1 1 ASP A 14 ARG A 19 1 6 HELIX 2 2 PRO A 20 ASP A 25 1 6 HELIX 3 3 TYR A 26 HIS A 29 5 4 HELIX 4 4 ASN A 35 ASP A 37 5 3 HELIX 5 5 LYS A 74 LEU A 88 1 15 HELIX 6 6 ASP A 120 TYR A 125 1 6 HELIX 7 7 THR A 129 MET A 150 1 22 HELIX 8 8 LYS A 158 HIS A 160 5 3 HELIX 9 9 SER A 194 LYS A 198 5 5 HELIX 10 10 GLY A 199 VAL A 204 1 6 HELIX 11 11 TYR A 211 ARG A 228 1 18 HELIX 12 12 ASP A 237 GLY A 250 1 14 HELIX 13 13 THR A 251 TYR A 261 1 11 HELIX 14 14 ASP A 266 ASP A 271 5 6 HELIX 15 15 ASN A 289 VAL A 293 5 5 HELIX 16 16 SER A 294 LEU A 305 1 12 HELIX 17 17 THR A 314 GLU A 320 1 7 HELIX 18 18 HIS A 321 TYR A 325 5 5 SHEET 1 A 5 TYR A 39 ARG A 47 0 SHEET 2 A 5 SER A 51 ASN A 58 -1 O GLU A 55 N VAL A 42 SHEET 3 A 5 LYS A 64 LEU A 70 -1 O VAL A 67 N PHE A 54 SHEET 4 A 5 PRO A 109 PHE A 113 -1 O PHE A 113 N VAL A 66 SHEET 5 A 5 LEU A 97 LYS A 102 -1 N VAL A 101 O ALA A 110 SHEET 1 B 2 ILE A 152 MET A 153 0 SHEET 2 B 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 C 2 VAL A 162 ASP A 165 0 SHEET 2 C 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 CISPEP 1 GLU A 230 PRO A 231 0 -1.55 CRYST1 58.676 45.954 63.956 90.00 111.82 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017043 0.000000 0.006824 0.00000 SCALE2 0.000000 0.021761 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016842 0.00000